Sodium Oxybate

羟丁酸钠

Report date: 2025/10/27 17:55:04
NME

Base Information

Drug NameSodium Oxybate
Drug Alias NameXyremHopveusJZP-6GHB
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStress Disorders, Post-TraumaticSchizophreniaBinge-Eating Disorder +[16
Global Approved IndicationsCataplexyNarcolepsyAnesthesia
Approved Indications in ChinaAnesthesia
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[13
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJazz Pharmaceuticals PlcUcb
China Registration ClassN/A

Develop Information

Active IndicationsCataplexyNarcolepsyDisorders of Excessive Somnolence +[5
Inactive IndicationsStress Disorders, Post-TraumaticSchizophreniaBinge-Eating Disorder +[11

Other Information

ATC CodeN01AX11N07XX04